GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (NSE:SANOFI) » Definitions » Equity-to-Asset

Sanofi India (NSE:SANOFI) Equity-to-Asset : 0.59 (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Sanofi India Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sanofi India's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹10,152 Mil. Sanofi India's Total Assets for the quarter that ended in Dec. 2023 was ₹17,148 Mil. Therefore, Sanofi India's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.59.

The historical rank and industry rank for Sanofi India's Equity-to-Asset or its related term are showing as below:

NSE:SANOFI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.59   Med: 0.73   Max: 0.75
Current: 0.59

During the past 13 years, the highest Equity to Asset Ratio of Sanofi India was 0.75. The lowest was 0.59. And the median was 0.73.

NSE:SANOFI's Equity-to-Asset is ranked better than
51.93% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs NSE:SANOFI: 0.59

Sanofi India Equity-to-Asset Historical Data

The historical data trend for Sanofi India's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Equity-to-Asset Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.73 0.73 0.62 0.59

Sanofi India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 - 0.48 - 0.59

Competitive Comparison of Sanofi India's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Sanofi India's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi India's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi India's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sanofi India's Equity-to-Asset falls into.



Sanofi India Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sanofi India's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=10152/17148
=0.59

Sanofi India's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=10152/17148
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanofi India  (NSE:SANOFI) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sanofi India Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sanofi India's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India (NSE:SANOFI) Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (NSE:SANOFI) Headlines

No Headlines